Saturday, September 24, 2011

LUPIN, SUN PHARMA AND Cipla - SHOWING HEALTHY GROWTH


Among the top 10 Indian Pharma companies, Sun, Cipla and Lupin have the most robust growth fundamentals. The growth of these companies is very healthy, being driven by new products and volume of existing products. . In a competitive market like India, Sun pharma has been able to execute the highest price increase, which shows strength of its product portfolio from a competitive perspective.